{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T14:08:08Z","timestamp":1793110088800,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T00:00:00Z","timestamp":1686009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T00:00:00Z","timestamp":1686009600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s10753-023-01834-1","type":"journal-article","created":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T03:24:19Z","timestamp":1686021859000},"page":"1697-1708","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["SPI1 Regulates the Progression of Ankylosing Spondylitis by Modulating TLR5 via NF-\u03baB Signaling"],"prefix":"10.1007","volume":"46","author":[{"given":"Dai","family":"Wenbo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Yifu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,6]]},"reference":[{"issue":"suppl_6","key":"1834_CR1","doi-asserted-by":"publisher","first-page":"vi4","DOI":"10.1093\/rheumatology\/key001","volume":"57","author":"D Simone","year":"2018","unstructured":"Simone, D., M. H. Al Mossawi, and P. Bowness. 2018. Progress in our understanding of the pathogenesis of ankylosing spondylitis. Rheumatology (Oxford)\u00a057 (suppl_6): vi4-vi9. https:\/\/doi.org\/10.1093\/rheumatology\/key001.","journal-title":"Rheumatology (Oxford)"},{"key":"1834_CR2","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41413-019-0057-8","volume":"7","author":"W Zhu","year":"2019","unstructured":"Zhu, W., X. He, K. Cheng, et al. 2019. Ankylosing spondylitis: Etiology, pathogenesis, and treatments. Bone Research 7: 22. https:\/\/doi.org\/10.1038\/s41413-019-0057-8.","journal-title":"Bone Res"},{"issue":"3","key":"1834_CR3","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.berh.2010.01.005","volume":"24","author":"G Schett","year":"2010","unstructured":"Schett, G., and M. Rudwaleit. 2010. Can we stop progression of ankylosing spondylitis? Best Practice & Research Clinical Rheumatology 24 (3): 363\u2013371. https:\/\/doi.org\/10.1016\/j.berh.2010.01.005.","journal-title":"Best Practice & Research Clinical Rheumatology"},{"issue":"7","key":"1834_CR4","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1074\/mcp.RA117.000565","volume":"17","author":"A Sanz-Bravo","year":"2018","unstructured":"Sanz-Bravo, A., C. Alvarez-Navarro, A. Martin-Esteban, et al. 2018. Ranking the contribution of ankylosing spondylitis-associated endoplasmic reticulum aminopeptidase 1 (ERAP1) polymorphisms to shaping the HLA-B*27 peptidome. Molecular and Cellular Proteomics 17 (7): 1308\u20131323. https:\/\/doi.org\/10.1074\/mcp.RA117.000565.","journal-title":"Molecular and Cellular Proteomics"},{"issue":"3","key":"1834_CR5","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s00774-017-0846-3","volume":"36","author":"S Jo","year":"2018","unstructured":"Jo, S., S. Kang, J. Han, et al. 2018. Accelerated osteogenic differentiation of human bone-derived cells in ankylosing spondylitis. Journal of Bone and Mineral Metabolism 36 (3): 307\u2013313. https:\/\/doi.org\/10.1007\/s00774-017-0846-3.","journal-title":"Journal of Bone and Mineral Metabolism"},{"issue":"5","key":"1834_CR6","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/s41419-019-1586-1","volume":"10","author":"G Zheng","year":"2019","unstructured":"Zheng, G., Z. Xie, P. Wang, et al. 2019. Enhanced osteogenic differentiation of mesenchymal stem cells in ankylosing spondylitis: a study based on a three-dimensional biomimetic environment. Cell Death & Disease 10 (5): 350. https:\/\/doi.org\/10.1038\/s41419-019-1586-1.","journal-title":"Cell Death & Disease"},{"key":"1834_CR7","doi-asserted-by":"publisher","unstructured":"Kastner, P., and S. Chan. 2008. PU.1: a crucial and versatile player in hematopoiesis and leukemia.\u00a0International Journal of Biochemistry & Cell Biology 40 (1): 22\u201327. https:\/\/doi.org\/10.1016\/j.biocel.2007.01.026.","DOI":"10.1016\/j.biocel.2007.01.026"},{"key":"1834_CR8","doi-asserted-by":"publisher","unstructured":"Iwasaki, H., C. Somoza, H. Shigematsu, et al. 2005. Distinctive and indispensable roles of PU.1 in maintenance of hematopoietic stem cells and their differentiation. Blood 106 (5): 1590\u20131600. https:\/\/doi.org\/10.1182\/blood-2005-03-0860.","DOI":"10.1182\/blood-2005-03-0860"},{"key":"1834_CR9","doi-asserted-by":"publisher","unstructured":"Sharma, S.M., A. Bronisz, R. Hu, et al. 2007. MITF and PU.1 recruit p38 MAPK and NFATc1 to target genes during osteoclast differentiation.\u00a0Journal of Biological Chemistry\u00a0282 (21): 15921\u201315929.\u00a0https:\/\/doi.org\/10.1074\/jbc.M609723200.","DOI":"10.1074\/jbc.M609723200"},{"key":"1834_CR10","doi-asserted-by":"publisher","unstructured":"Jules, J., Y.P. Li, and W. Chen. 2018. C\/EBPalpha and PU.1 exhibit different responses to RANK signaling for osteoclastogenesis. Bone\u00a0107: 104\u2013114.\u00a0https:\/\/doi.org\/10.1016\/j.bone.2017.05.009.","DOI":"10.1016\/j.bone.2017.05.009"},{"key":"1834_CR11","doi-asserted-by":"publisher","unstructured":"Izawa, N., D. Kurotaki, and S. Nomura, et al. 2019. Cooperation of PU.1 with IRF8 and NFATc1 defines chromatin landscapes during RANKL-induced osteoclastogenesis.\u00a0Journal of Bone and Mineral Research\u00a034 (6): 1143\u20131154. https:\/\/doi.org\/10.1002\/jbmr.3689.","DOI":"10.1002\/jbmr.3689"},{"key":"1834_CR12","doi-asserted-by":"publisher","unstructured":"Tondravi, M.M., S.R. McKercher, K. Anderson, et al. 1997. Osteopetrosis in mice lacking haematopoietic transcription factor PU.1. Nature\u00a0386 (6620): 81\u201384.\u00a0https:\/\/doi.org\/10.1038\/386081a0.","DOI":"10.1038\/386081a0"},{"issue":"1","key":"1834_CR13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12865-022-00476-6","volume":"23","author":"T Liang","year":"2022","unstructured":"Liang, T., J. Chen, G. Xu, et al. 2022. STAT3 and SPI1, may lead to the immune system dysregulation and heterotopic ossification in ankylosing spondylitis. BMC Immunology 23 (1): 3. https:\/\/doi.org\/10.1186\/s12865-022-00476-6.","journal-title":"BMC Immunology"},{"issue":"7","key":"1834_CR14","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/nri1391","volume":"4","author":"S Akira","year":"2004","unstructured":"Akira, S., and K. Takeda. 2004. Toll-like receptor signalling. Nature Reviews Immunology 4 (7): 499\u2013511. https:\/\/doi.org\/10.1038\/nri1391.","journal-title":"Nature Reviews Immunology"},{"issue":"3","key":"1834_CR15","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.autrev.2007.11.006","volume":"7","author":"J Hurst","year":"2008","unstructured":"Hurst, J., and P. von Landenberg. 2008. Toll-like receptors and autoimmunity. Autoimmunity Reviews 7 (3): 204\u2013208. https:\/\/doi.org\/10.1016\/j.autrev.2007.11.006.","journal-title":"Autoimmunity Reviews"},{"issue":"6","key":"1834_CR16","doi-asserted-by":"publisher","first-page":"649","DOI":"10.2217\/IJR.11.61","volume":"6","author":"FK Tan","year":"2011","unstructured":"Tan, F.K., and K. Farheen. 2011. The potential importance of Toll-like receptors in ankylosing spondylitis.\u00a0International Journal of Clinical Rheumatology\u00a06 (6): 649\u2013654. https:\/\/doi.org\/10.2217\/IJR.11.61.","journal-title":"Int J Clin Rheumtol"},{"key":"1834_CR17","doi-asserted-by":"publisher","unstructured":"Barreto, G., M. Manninen, and K.K. Eklund. 2020. Osteoarthritis and toll-like receptors: when innate immunity meets chondrocyte apoptosis. Biology (Basel)\u00a09 (4).\u00a0https:\/\/doi.org\/10.3390\/biology9040065.","DOI":"10.3390\/biology9040065"},{"issue":"1","key":"1834_CR18","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3899\/jrheum.100469","volume":"38","author":"S Assassi","year":"2011","unstructured":"Assassi, S., J.D. Reveille, F.C. Arnett, et al. 2011. Whole-blood gene expression profiling in ankylosing spondylitis shows upregulation of toll-like receptor 4 and 5. Journal of Rheumatology 38 (1): 87\u201398. https:\/\/doi.org\/10.3899\/jrheum.100469.","journal-title":"Journal of Rheumatology"},{"issue":"3","key":"1834_CR19","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.cell.2008.01.020","volume":"132","author":"MS Hayden","year":"2008","unstructured":"Hayden, M.S., and S. Ghosh. 2008. Shared principles in NF-kappaB signaling. Cell 132 (3): 344\u2013362. https:\/\/doi.org\/10.1016\/j.cell.2008.01.020.","journal-title":"Cell"},{"key":"1834_CR20","doi-asserted-by":"publisher","unstructured":"Baltimore, D. 2009. Discovering NF-kappaB.\u00a0Cold Spring Harbor Perspectives in Biology\u00a01 (1): a000026.\u00a0https:\/\/doi.org\/10.1101\/cshperspect.a000026.","DOI":"10.1101\/cshperspect.a000026"},{"key":"1834_CR21","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-2180-4-33","volume":"4","author":"T Tallant","year":"2004","unstructured":"Tallant, T., A. Deb, N. Kar, et al. 2004. Flagellin acting via TLR5 is the major activator of key signaling pathways leading to NF-kappa B and proinflammatory gene program activation in intestinal epithelial cells. BMC Microbiology 4: 33. https:\/\/doi.org\/10.1186\/1471-2180-4-33.","journal-title":"BMC Microbiology"},{"issue":"2","key":"1834_CR22","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.bone.2009.04.252","volume":"45","author":"K Hess","year":"2009","unstructured":"Hess, K., A. Ushmorov, J. Fiedler, et al. 2009. TNFalpha promotes osteogenic differentiation of human mesenchymal stem cells by triggering the NF-kappaB signaling pathway. Bone 45 (2): 367\u2013376. https:\/\/doi.org\/10.1016\/j.bone.2009.04.252.","journal-title":"Bone"},{"issue":"12","key":"1834_CR23","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1002\/cbin.10141","volume":"37","author":"X Feng","year":"2013","unstructured":"Feng, X., G. Feng, J. Xing, et al. 2013. TNF-alpha triggers osteogenic differentiation of human dental pulp stem cells via the NF-kappaB signalling pathway. Cell Biology International 37 (12): 1267\u20131275. https:\/\/doi.org\/10.1002\/cbin.10141.","journal-title":"Cell Biology International"},{"key":"1834_CR24","doi-asserted-by":"publisher","unstructured":"Ding, L., Y. Yin, Y. Hou, et al. 2020. microRNA-214\u20133p suppresses ankylosing spondylitis fibroblast osteogenesis via BMP-TGFbeta axis and BMP2.\u00a0Frontiers in Endocrinology\u00a0(Lausanne)\u00a011 : 609753.\u00a0https:\/\/doi.org\/10.3389\/fendo.2020.609753.","DOI":"10.3389\/fendo.2020.609753"},{"issue":"1","key":"1834_CR25","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1023\/a:1010011209064","volume":"2","author":"JE Aubin","year":"2001","unstructured":"Aubin, J.E. 2001. Regulation of osteoblast formation and function. Reviews in Endocrine & Metabolic Disorders 2 (1): 81\u201394. https:\/\/doi.org\/10.1023\/a:1010011209064.","journal-title":"Reviews in Endocrine & Metabolic Disorders"},{"issue":"4","key":"1834_CR26","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s11926-017-0644-x","volume":"19","author":"MN Magrey","year":"2017","unstructured":"Magrey, M.N., and M.A. Khan. 2017. The paradox of bone formation and bone loss in ankylosing spondylitis: Evolving new concepts of bone formation and future trends in management. Current Rheumatology Reports 19 (4): 17. https:\/\/doi.org\/10.1007\/s11926-017-0644-x.","journal-title":"Current Rheumatology Reports"},{"issue":"4","key":"1834_CR27","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1002\/eji.202048878","volume":"51","author":"C Papagoras","year":"2021","unstructured":"Papagoras, C., A. Chrysanthopoulou, A. Mitsios, et al. 2021. IL-17A expressed on neutrophil extracellular traps promotes mesenchymal stem cell differentiation toward bone-forming cells in ankylosing spondylitis. European Journal of Immunology 51 (4): 930\u2013942. https:\/\/doi.org\/10.1002\/eji.202048878.","journal-title":"European Journal of Immunology"},{"key":"1834_CR28","doi-asserted-by":"publisher","unstructured":"Cui, H., Z. Li, S. Chen, et al. 2022. CXCL12\/CXCR4-Rac1-mediated migration of osteogenic precursor cells contributes to pathological new bone formation in ankylosing spondylitis. Science Advances\u00a08 (14): eabl8054.\u00a0https:\/\/doi.org\/10.1126\/sciadv.abl8054.","DOI":"10.1126\/sciadv.abl8054"},{"key":"1834_CR29","doi-asserted-by":"publisher","unstructured":"Luchin, A., S. Suchting, T. Merson, et al. 2001. Genetic and physical interactions between Microphthalmia transcription factor and PU.1 are necessary for osteoclast gene expression and differentiation.\u00a0Journal of Biological Chemistry 276 (39): 36703\u201336710.\u00a0https:\/\/doi.org\/10.1074\/jbc.M106418200.","DOI":"10.1074\/jbc.M106418200"},{"key":"1834_CR30","doi-asserted-by":"publisher","unstructured":"Matsumoto, M., M. Kogawa, S. Wada, et al. 2004. Essential role of p38 mitogen-activated protein kinase in cathepsin K gene expression during osteoclastogenesis through association of NFATc1 and PU.1.\u00a0Journal of Biological Chemistry\u00a0279 (44): 45969\u201345979. https:\/\/doi.org\/10.1074\/jbc.M408795200.","DOI":"10.1074\/jbc.M408795200"},{"key":"1834_CR31","doi-asserted-by":"publisher","first-page":"117954411775162","DOI":"10.1177\/1179544117751627","volume":"11","author":"A Akassou","year":"2018","unstructured":"Akassou, A., and Y. Bakri. 2018. Does HLA-B27 Status influence ankylosing spondylitis phenotype?\u00a0Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders\u00a011: 1179544117751627. https:\/\/doi.org\/10.1177\/1179544117751627.","journal-title":"Clin Med Insights Arthritis Musculoskelet Disord"},{"key":"1834_CR32","doi-asserted-by":"publisher","unstructured":"Rehli, M., A. Poltorak, L. Schwarzfischer, et al. 2000. PU.1 and interferon consensus sequence-binding protein regulate the myeloid expression of the human Toll-like receptor 4 gene. Journal of Biological Chemistry\u00a0275 (13): 9773\u20139781.\u00a0https:\/\/doi.org\/10.1074\/jbc.275.13.9773.","DOI":"10.1074\/jbc.275.13.9773"},{"issue":"4","key":"1834_CR33","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1002\/JPER.18-0251","volume":"90","author":"Y Zhu","year":"2019","unstructured":"Zhu, Y., Q. Li, Y. Zhou, et al. 2019. TLR activation inhibits the osteogenic potential of human periodontal ligament stem cells through Akt signaling in a Myd88- or TRIF-dependent manner. Journal of Periodontology 90 (4): 400\u2013415. https:\/\/doi.org\/10.1002\/JPER.18-0251.","journal-title":"Journal of Periodontology"},{"key":"1834_CR34","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3389\/fimmu.2018.00072","volume":"9","author":"Y Lu","year":"2018","unstructured":"Lu, Y., X. Li, S. Liu, et al. 2018. Toll-like receptors and inflammatory bowel disease. Frontiers in Immunology 9: 72. https:\/\/doi.org\/10.3389\/fimmu.2018.00072.","journal-title":"Frontiers in Immunology"},{"key":"1834_CR35","doi-asserted-by":"publisher","unstructured":"Christian, F., E.L. Smith, and R.J. Carmody. 2016. The regulation of NF-kappaB subunits by phosphorylation. Cells\u00a05 (1).\u00a0https:\/\/doi.org\/10.3390\/cells5010012.","DOI":"10.3390\/cells5010012"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-023-01834-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10753-023-01834-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-023-01834-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T08:23:56Z","timestamp":1697012636000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10753-023-01834-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,6]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["1834"],"URL":"https:\/\/doi.org\/10.1007\/s10753-023-01834-1","relation":{},"ISSN":["0360-3997","1573-2576"],"issn-type":[{"value":"0360-3997","type":"print"},{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,6]]},"assertion":[{"value":"29 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Review Committee of Affiliated Hospital of Guilin Medical University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}